Cargando…
A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma
BACKGROUND: Angiosarcoma is a rare subgroup of soft tissue sarcomas associated with poor prognosis, but paclitaxel has been shown to be active in pretreated metastatic disease. We investigated the efficacy and safety of weekly paclitaxel as first-line chemotherapy in adult patients with metastatic a...
Autores principales: | Byeon, Seonggyu, Song, Haa-Na, Kim, Hee Kyung, Ham, Jun Soo, Lee, Su Jin, Lee, Jeeyun, Park, Se Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864900/ https://www.ncbi.nlm.nih.gov/pubmed/27175275 http://dx.doi.org/10.1186/s13569-016-0048-0 |
Ejemplares similares
-
Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma
por: Fiste, Oraianthi, et al.
Publicado: (2020) -
Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
por: Lee, Su Jin, et al.
Publicado: (2015) -
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma
por: Apice, Gaetano, et al.
Publicado: (2016) -
A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma
por: Bui, Nam, et al.
Publicado: (2018) -
A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
por: Kim, Jung Sun, et al.
Publicado: (2022)